RE: Val201 news30 Dec 2024 21:47
UNITED STATES, December 30, 2024 /EINPresswire.com/ -- TheoremRx Inc. (“TheoremRx”), a private biotechnology company focused on the development of new treatments for patients suffering from cancer and women’s health conditions, announced today that TheoremRx has signed a letter of intent dated December 23, 2024, with respect to a proposed transaction with a NASDAQ listed company.